FDA Inspection 1327582 — Cancer Diagnostics Inc.

Cancer Diagnostics Inc. — FEI 3007496191

The FDA completed an inspection of Cancer Diagnostics Inc. on Jul 23, 2026 in Durham, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 23, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Durham, NC (United States)

Citations

IDCFRDescription
2279521 CFR 801.20(a)Label to bear a unique device identifier
23236ISO 13485:2016 Clause 8.3.1Nonconforming product not identified and controlled

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.